undefined undefined
NaN.000
NaN.00%
Monopar Therapeutics (NASDAQ:MNPR) on Tuesday announced the filing of a provisional patent application regarding the recent advancements the company has achieved with its MNPR-101 radiopharmaceutical ...
04-16 20:18
Monopar Therapeutics Inc (MNPR) has shared an announcement. Monopar Therapeutic...
04-16 20:13
JonesTrading:上调Monopar Therapeutics(MNPR.US)评级,由持有调整至买入评级, 目标价2.00美元。
04-11 19:41
JonesTrading analyst Soumit Roy upgrades Monopar Therapeutics (NASDAQ:MNPR) from Hold to Buy and announces $2 price target.
04-11 19:39
Unity Software(U.US) reported fourth-quarter financial results after the market...
04-11 19:39
Monopar Therapeutics Inc (MNPR) has provided an update. Monopar Therapeutics In...
04-10 20:12
12月31日,Monopar Therapeutics Inc.(MNPR.US)公布财报,公告显示公司2023财年净利润为-8.40百万美元,同比增加20....
03-30 02:13
Monopar Therapeutics press release (NASDAQ:MNPR): Q4 GAAP EPS of -$0.12. Cash, cash equivalents and short-term investments as of December 31, 2023, were $7.3 million. More on Monopar Therapeutics Top ...
03-29 03:26
Monopar Therapeutics (NASDAQ:MNPR) reported its Q4 earnings results on Thursday...
03-28 19:45
Monopar Therapeutics (NASDAQ:MNPR) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.15) by 20 percent. This is a 45.45 percent increase over losses of $(0.22) per share from
03-28 19:26